FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-15.32%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$522M
AUM Growth
+$522M
(+51%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
41.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
|
$215M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVLO
1
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $215M | 41.21% |
+18,233,403
| New | +$215M |
|
2
Denali Therapeutics
DNLI
$2.23B
| $136M | 26.05% |
8,918,749
| – | – |
|
3
Seres Therapeutics
MCRB
$166M
| $109M | 20.89% |
12,682,876
| – | – |
|
|
SYRS
4
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $32.7M | 6.27% |
3,204,437
| – | – |
|
5
Quanterix
QTRX
$211M
| $29.2M | 5.58% |
2,030,495
| – | – |
|